Groundwork BioAg and NovaTero expand mycorrhizal bio-platform
Groundwork BioAg and its exclusive Brazilian distribution partner, NovaTero BioAg, have announced a new product offering for Brazilian farmers this growing season, Rootella BR Ultra, which expands the reach to in-furrow and seed treatment application methods in soybean, corn, and other cereals.
- READ MORE: Start-up spotlight: Groundwork BioAg
Rootella BR Ultra is the highest concentrated mycorrhizal inoculant on the market, containing 167,000 viable propagules per gram of Rhizophagus intraradices, with an application rate of as low as 15 grams per hectare.
“As farmers manage the unseasonably dry weather, our expanded product portfolio offers additional choices for farmers in Brazil, especially as many switch to safrinha,” Bernardo Arnaud, NovaTero chairman says. “Farmers across Brazil continue to benefit from adding Rootella to their farm management practices to protect soil and plant health while extending above- and below-ground insurance against environmental stresses.”
For the past three years, NovaTero has helped Brazilian farmers to naturally increase yield, reduce dependency on phosphorus, and improve carbon sequestration in soil by applying the proven Rootella BR mycorrhizae inoculants. “As part of our strategy to expand our mycorrhizal bio-platform, we continue to set the standard for concentration of cost-effective, commercial-scale mycorrhizae,” says Yossi Kofman, co-founder and chief executive officer of Groundwork BioAg.
Kofman adds, “As the impact of climate change continues around the world, we are committed to help increase the productivity of major crops – like those in key breadbaskets such as Brazil. As the ‘queen of biologicals,’ mycorrhiza offers the strongest natural defense against chronic drought while reducing the need for synthetic fertilizers.”
After being granted the only definitive commercial registration in Brazil, the companies’ exclusive partnership has accelerated innovation to meet demand of the rapidly growing Brazilian market, where the biologicals market is projected to show a double digit CAGR in the coming years.
The Rootella BR portfolio includes two of the most concentrated formulations of mycorrhizae on the market today.